About this trial
Stroke is a major cause of long-term disability and is often associated with reduced quality of life, depression, anxiety, and fatigue. Rehabilitation plays a key role in recovery, and robotic-assisted gait training provides intensive, repetitive, and individualized therapy. However, its effects on psychological outcomes and quality of life are not fully established.
This randomized controlled trial will compare conventional rehabilitation combined with robotic-assisted gait training to conventional rehabilitation combined with treadmill training in stroke survivors. Both groups will receive treatment 5 days per week for 6 weeks.
Assessments will be conducted at baseline, after 6 weeks of treatment, and at 3 months after treatment. The primary outcome is quality of life. Secondary outcomes include depression, anxiety, and fatigue. The results of this study will provide new evidence on the benefits of robotic rehabilitation for improving both physical and psychological well-being after stroke.
Eligibility criteria
Qualifiers
Age between 18 and 75 years
History of ischemic or hemorrhagic stroke at least 3 months prior to enrollment
Mini Mental State Examination (MMSE) score of 24 or higher
Modified Ashworth Scale score < 2 in the lower extremities
Disqualifiers
Severe cognitive or communication impairment
Mobility limitations due to joint contracture or deformity
Presence of open wounds or pressure ulcers
Uncontrolled hypertension or orthostatic hypotension
Trial design
Treatments tested in this trial
- RoboGait® Robotic Gait Training
- Treadmill Walking Training
Treatment groups
Locations
Sponsors and collaborators
Meltem Gunes Akinci
Lead sponsor
Pamukkale University
Sponsor institution